Top 10 Blue Chip Stocks To Watch Right Now

Dividend growth investing can be a great way to boost your passive income over time. To do it right, though, you have to find stocks that can both grow their dividends faster than inflation and have sustainable free cash flows for the long haul.

Gilead Sciences (NASDAQ:GILD), a blue chip biotech stock, meets both of these critical criteria. Even so, this top biotech is rarely considered purely for its prospects as a dividend growth stock. The reason? Gilead only started doling out a dividend approximately three years ago this month. As a result, the company has yet to shed its well-earned image as a top growth stock within the broader investing community. 

Image Source: Getty Images.

However, I think this underappreciated dividend growth play is worth adding to your portfolio right now. Here’s why.      

Gilead’s risks are overstated

There are two big knocks against Gilead as a dividend growth stock. First off, the company’s hepatitis C franchise has literally imploded since hitting a high watermark in late 2015. Gilead has thus had to rely on its core HIV franchise to pick up the slack, and that strategy has so far failed to keep the company’s top line moving in the right direction. Despite several new product launches in HIV, the biotech’s top line remains on track to drop by a disastrous 20.3% this year.

Top 10 Blue Chip Stocks To Watch Right Now: Summit Midstream Partners, LP(SMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the many companies working to solve the Permian’s pipeline problems is Summit Midstream Partners (NYSE:SMLP). The master limited partnership (MLP) is currently working on a long-haul pipeline that would transport natural gas from the northwest portion of the region to a major hub in Texas. The project would not only provide needle-moving growth for Summit — and help support its sky-high 14.5%-yielding distribution — but it could be a crucial supply link for the industry.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Summit Midstream Partners (SMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Three high-yield dividend stocks that seem to be in danger of a dividend reduction are Summit Midstream Partners (NYSE:SMLP), Enbridge Energy Partners (NYSE:EEP), and Sunoco LP (NYSE:SUN). Investors are better off steering clear of this trio and considering safer options instead.

  • [By Joseph Griffin]

    Summit Midstream Partners (NYSE:SMLP) insider Brad N. Graves sold 5,000 shares of the stock in a transaction dated Thursday, May 17th. The stock was sold at an average price of $15.53, for a total transaction of $77,650.00. Following the sale, the insider now owns 61,225 shares of the company’s stock, valued at approximately $950,824.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Max Byerly]

    Summit Midstream Partners (NYSE:SMLP) released its quarterly earnings data on Thursday. The pipeline company reported ($0.18) EPS for the quarter, missing the consensus estimate of $0.12 by ($0.30), MarketWatch Earnings reports. Summit Midstream Partners had a return on equity of 12.62% and a net margin of 17.59%. The business had revenue of $117.32 million during the quarter, compared to the consensus estimate of $106.68 million.

Top 10 Blue Chip Stocks To Watch Right Now: EQT Corporation(EQT)

Advisors’ Opinion:

  • [By ]

    In addition, Elliott Management, which often pushes for M&A and other strategic transactions at targeted companies, made investments in EQT Corp. (EQT) , CommVault Systems Inc. (CVLT) , Sabre Corp. (SABR) , Teradyne Inc. (TER)  and Windstream Holdings Inc. (WIN)

  • [By Ethan Ryder]

    Mount Yale Investment Advisors LLC acquired a new stake in shares of EQT Co. (NYSE:EQT) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,022 shares of the oil and gas producer’s stock, valued at approximately $191,000.

  • [By Matthew DiLallo, Jason Hall, and Tyler Crowe]

    Tyler, Jason, and I (Matt here) were recently discussing why natural gas stocks have taken it on the chin over the past year. While some have been the victim of their own mistakes, shares of many of the country’s largest gas-focused producers have lost value even though oil prices have been on the upswing. For example, the country’s leading gas producer, EQT Corp. (NYSE:EQT), has seen its stock tumble more than 20%, while other large gas-focused companies such as Antero Resources (NYSE:AR), Cabot Oil & Gas (NYSE:COG), and Southwestern Energy have declined between 5% and 15% over the past 12 months. Those sell-offs caught our attention. Here’s what we think is weighing down gas stocks these days. 

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was EQT Corp. (NYSE: EQT) which rose about 10% to $53.35. The stock’s 52-week range is $43.70 to $67.84. Volume was nearly 11 million compared to the daily average volume of 3.6 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was EQT Corp. (NYSE: EQT) which traded down over 5% at $49.72. The stock’s 52-week range is $43.70 to $67.84. Volume was 7.6 million compared to the daily average volume of nearly 4 million.

Top 10 Blue Chip Stocks To Watch Right Now: Ultra Clean Holdings, Inc.(UCTT)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Ultra Clean Holdings Inc. (NASDAQ:UCTT) declined 19.2% in July, according to data from S&P Global Market Intelligence, after the semiconductor equipment specialist announced mixed second-quarter 2018 results and disappointing forward guidance.

  • [By Max Byerly]

    Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Ultra Clean alerts:

    Comparing Rubicon Technology (RBCN) & Ultra Clean (UCTT) (americanbankingnews.com) Ultra Clean Holdings Inc (UCTT) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com) Spiffy Stocks: Daktronics, Inc. (NASDAQ:DAKT), Ultra Clean Holdings, Inc. (NASDAQ:UCTT), Galectin Therapeutics, Inc … (thestreetpoint.com) Ultra Clean Holdings, Inc. — Moody’s assigns B1 CFR to Ultra Clean Holdings; outlook stable (finance.yahoo.com)

    Several analysts recently weighed in on UCTT shares. Zacks Investment Research cut Ultra Clean from a “hold” rating to a “strong sell” rating in a report on Friday, August 3rd. BidaskClub raised Ultra Clean from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 30th. Stifel Nicolaus lifted their price target on Ultra Clean from $27.00 to $30.00 and gave the stock a “buy” rating in a report on Monday, June 18th. Standpoint Research raised Ultra Clean from a “hold” rating to a “buy” rating in a report on Tuesday, August 28th. Finally, ValuEngine cut Ultra Clean from a “sell” rating to a “strong sell” rating in a report on Friday, May 18th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. Ultra Clean presently has a consensus rating of “Hold” and an average target price of $28.20.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Motley Fool Transcribing]

    Ultra Clean Holdings (NASDAQ:UCTT) Q4 2018 Earnings Conference CallFeb. 21, 2019 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Headlines about Ultra Clean (NASDAQ:UCTT) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Ultra Clean earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned media stories about the semiconductor company an impact score of 45.3293552269826 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Shane Hupp]

    Employees Retirement System of Texas reduced its stake in shares of Ultra Clean Holdings Inc (NASDAQ:UCTT) by 24.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177,000 shares of the semiconductor company’s stock after selling 57,000 shares during the quarter. Employees Retirement System of Texas owned 0.46% of Ultra Clean worth $2,938,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Watch Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.19. Investors who bought at $2.55 are sitting on a 53.3% loss today (Feb. 20).

  • [By Logan Wallace]

    Maxim Group assumed coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN). The firm issued a buy rating on the stock.

    Sanford C. Bernstein assumed coverage on shares of Zimmer Biomet (NYSE:ZBH). Sanford C. Bernstein issued an underperform rating on the stock.

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

Top 10 Blue Chip Stocks To Watch Right Now: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    1ST RES BK EXTO/SH (OTCMKTS:FRSB) and First of Long Island (NASDAQ:FLIC) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

  • [By Logan Wallace]

    First of Long Island Corp (NASDAQ:FLIC) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $21.30 and last traded at $21.60, with a volume of 237 shares. The stock had previously closed at $21.50.

  • [By Stephan Byrd]

    First of Long Island (NASDAQ:FLIC) and 1ST RES BK EXTO/SH (OTCMKTS:FRSB) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “First of Long Island Corp (FLIC) Position Trimmed by ClariVest Asset Management LLC” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/4167612/first-of-long-island-corp-flic-position-trimmed-by-clarivest-asset-management-llc.html.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First of Long Island (FLIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Watch Right Now: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Lee Jackson]

    Jefferies started coverage on this biotech/medical technology company with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Maxx Chatsko]

    Shares of AxoGen (NASDAQ:AXGN) fell nearly 19% today after the company reported second-quarter 2018 earnings. The healthcare company, which develops and markets surgical solutions for peripheral nerves, actually reported a solid quarter of sales growth compared to the year-ago period. Revenue increased 36% compared to the second quarter of 2017.

  • [By Max Byerly]

    AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

Top 10 Blue Chip Stocks To Watch Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By ]

    On Tuesday, BP (BP) , Merck (MRK) , Under Armour (UAA) and Apple (AAPL) will be reporting. Cramer was bullish on all of them, except Apple, where he said this Action Alerts PLUS holding could report a less-than-optimal quarter.

  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Wednesday was Merck & Co. Inc. (NYSE: MRK) which traded up about 2.55% at $55.12. The stock’s 52-week range is $52.97 to $66.41. Volume was about 30% below the daily average of around 13 million. The company had no specific news.

  • [By Todd Campbell]

    Because statins are so widely used, they’re the most prescribed medicines in the world, and that’s been a bonanza for companies like Pfizer (NYSE:PFE), which developed top-selling cholesterol drug Lipitor, and Merck & Co. (NYSE:MRK), which created cholesterol-lowering add-on therapy Zetia.

  • [By Money Morning News Team]

    BioLine has developed key partnerships with major pharmaceutical companies, which helps bring its drugs to market faster once they have gained some clinical trial success. Two of its biggest partners are Merck & Co. Inc. (NYSE: MRK) and Novartis AG (NYSE: NVS).

  • [By ]

    While immunotherapy has definitely been a revolutionary advance in science and medicine, it has not been the panacea some had hoped for. For one, it’s not a cure. Further, this approach works better for some types of cancers than for others. Merck’s (NYSE: MRK) cancer treatment Keytruda, for instance, is FDA-approved for specific forms and stages of melanoma, lung cancer, neck cancer, classical Hodgkin Lymphoma and a few more — a lot, but still not a universal cure. Sales of Keytruda, however, exceeded $1 billion in the third quarter of 2017, which was reported Oct. 27. (Some missteps from Merck’s closest competitor, Bristol-Myers Squibb (NYSE: BMY), helped too.)

  • [By Chris Lange]

    The number of Merck & Co. Inc. (NYSE: MRK) shares short decreased to 19.98 million from 20.40 million in the previous period. Its shares were trading at $59.40, in a 52-week range of $52.83 to $66.41.

Top 10 Blue Chip Stocks To Watch Right Now: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of Apogee Enterprises (NASDAQ:APOG) from a buy rating to a strong-buy rating in a research report sent to investors on Wednesday morning.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, including gains of nearly 200 points for the Dow Jones Industrial Average and similarly positive moves for other major benchmarks. At first glance, decisions from the U.S. and China to impose new tariffs on each other might have seemed like bad news, but investors were pleased that the actual tariff rates on the goods covered by the measures were less severe than initially feared. Even with that as a positive backdrop, some companies weren’t able to avoid bad news that sent their shares lower. Tesla (NASDAQ:TSLA), Apogee Enterprises (NASDAQ:APOG), and General Mills (NYSE:GIS) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Stocks to Watch Today: V, MA, AAPL, GOOGL
    Visa Inc. (NYSE: V) and Mastercard Inc. (NYSE: MA) are under the microscope this morning. Both payment processing giants have signed a settlement agreement over a merchant lawsuit filed back in 2005, but originally settled in 2012 over merchant swiping fees. Visa will pay an additional $600 million to the original settlement. Mastercard will pay an additional $108 million. Although President Trump plans to hit China with new tariffs, at least one company won’t face the full cost: Apple Inc. (NASDAQ: AAPL). According to reports, the Apple Watch is among a list of consumer tech gadgets that will receive exemptions from the latest round of tariffs on imports. Alphabet Inc. (NASDAQ: GOOGL) announced it will install its Android operating system into automobiles manufactured by Nissan, Mitsubishi, and Renault. The operating system – set for distribution in 2021 – will include Google Maps, Google Assistant, and Google Play. The three manufacturers combined sold 10.6 million vehicles in 2017. Look for earnings reports from AutoZone Inc. (NYSE: AZO), General Mills Inc. (NYSE: GIS), Cracker Barrel Old Country Store Inc. (NASDAQ: CBRL), and Apogee Enterprises Inc. (Nasdaq: APOG).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By ]

    Engaged Capital’s Glenn Welling plans shortly to launch an activist campaign at Apogee Enterprises Inc. (APOG) , a maker of glass and non-residential construction products for skyscrapers, a person familiar with the situation told Orol.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Apogee Enterprises (APOG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
    Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
    Four Stocks to Watch Today: BLK, FB, DAL
    Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
    The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
    Delta Air Lines Inc. (NYSE: DAL) reported ea

Top 10 Blue Chip Stocks To Watch Right Now: Bluerock Residential Growth REIT, Inc.(BRG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Bluerock Residential Growth REIT (NASDAQ:BRG) has trended somewhat positive on Sunday, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bluerock Residential Growth REIT earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the company an impact score of 47.1792961215955 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Shane Hupp]

    A number of research analysts have commented on BRG shares. Zacks Investment Research raised shares of Bluerock Residential Growth REIT from a “hold” rating to a “buy” rating and set a $12.00 target price on the stock in a research report on Friday, February 15th. Boenning Scattergood reissued a “buy” rating and set a $11.00 target price on shares of Bluerock Residential Growth REIT in a research report on Tuesday, November 6th. B. Riley reissued a “buy” rating on shares of Bluerock Residential Growth REIT in a research report on Tuesday, November 6th. Finally, TheStreet raised shares of Bluerock Residential Growth REIT from a “d+” rating to a “c-” rating in a research report on Thursday, January 24th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $11.17.

    COPYRIGHT VIOLATION NOTICE: “Bluerock Residential Growth REIT Inc (BRG) Shares Sold by National Asset Management Inc.” was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4188619/bluerock-residential-growth-reit-inc-brg-shares-sold-by-national-asset-management-inc.html.

    About Bluerock Residential Growth REIT

  • [By Shane Hupp]

    Bluerock Residential Growth REIT Inc Class A (NYSEAMERICAN:BRG) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 1,697,945 shares, a decrease of 7.7% from the August 15th total of 1,840,022 shares. Approximately 7.2% of the shares of the company are short sold. Based on an average daily trading volume, of 110,334 shares, the days-to-cover ratio is presently 15.4 days.

Top 10 Blue Chip Stocks To Watch Right Now: Valmont Industries, Inc.(VMI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Valmont Industries (VMI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Schroder Investment Management Group cut its stake in Valmont Industries (NYSE:VMI) by 1.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 689,795 shares of the industrial products company’s stock after selling 9,086 shares during the period. Schroder Investment Management Group owned approximately 3.06% of Valmont Industries worth $100,917,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Alps Advisors Inc. bought a new stake in Valmont Industries, Inc. (NYSE:VMI) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,686 shares of the industrial products company’s stock, valued at approximately $611,000.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Valmont Industries (VMI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Rhumbline Advisers reduced its stake in Valmont Industries, Inc. (NYSE:VMI) by 1.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,597 shares of the industrial products company’s stock after selling 598 shares during the period. Rhumbline Advisers owned 0.19% of Valmont Industries worth $6,271,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    A number of analysts have recently commented on VMI shares. Boenning Scattergood restated a “hold” rating on shares of Valmont Industries in a report on Wednesday, October 24th. ValuEngine upgraded Valmont Industries from a “sell” rating to a “hold” rating in a report on Thursday, November 1st. Finally, Zacks Investment Research downgraded Valmont Industries from a “hold” rating to a “sell” rating in a research report on Saturday, January 5th. Four equities research analysts have rated the stock with a hold rating, The company presently has an average rating of “Hold” and an average price target of $165.00.

    TRADEMARK VIOLATION NOTICE: “Valmont Industries (VMI) to Release Earnings on Wednesday” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at www.tickerreport.com/banking-finance/4147439/valmont-industries-vmi-to-release-earnings-on-wednesday.html.

    Valmont Industries Company Profile

Leave a Reply

Your email address will not be published. Required fields are marked *